|
News Shire Acquires US Rights to Resolor
Shire, the global specialty biopharmaceutical company, announced that it has acquired the rights to develop and market Resolor® (prucalopride) in the United States (US) in an agreement with Janssen Pharmaceutica N.V. |
|
Leaflet Drug Resolor
Resolor is a medicine that contains the active substance prucalopride. It is available as round tablets (white: 1 mg and pink: 2 mg). |